Ras–MAPK Pathway

Core Concept

The Ras–MAPK pathway is the principal route by which receptor tyrosine kinases drive cell proliferation. Ligand-activated RTKs recruit the adaptor Grb2, which recruits the guanine nucleotide exchange factor (GEF) SOS; SOS converts the small GTPase Ras to its active GTP-bound form. Active Ras recruits and activates the kinase Raf, which phosphorylates MEK, which phosphorylates ERK (MAP kinase). Activated ERK translocates to the nucleus and phosphorylates transcription factors (e.g., Elk-1) that drive immediate-early genes controlling cell-cycle entry and differentiation. Ras is a monomeric small GTPase — a binary molecular switch whose activity is governed by GEFs (on) and GTPase-activating proteins, or GAPs (off).

Key Components

• RTK: Activated upstream, provides the phosphotyrosine docking site.
• Grb2: Adaptor (SH2 + two SH3); SH2 binds receptor pTyr, SH3s bind SOS.
• SOS: Guanine nucleotide exchange factor (GEF) for Ras.
• Ras: Monomeric (~21 kDa) small GTPase; membrane-anchored by lipid modification (farnesyl group).
• Raf: MAP kinase kinase kinase (MAPKKK), a Ser/Thr kinase recruited by Ras-GTP.
• MEK: MAP kinase kinase (MAPKK); dual-specificity kinase.
• ERK: Mitogen-activated protein kinase (MAPK); the effector kinase.
• GAPs (e.g., NF1): Accelerate Ras's slow intrinsic GTP hydrolysis, turning Ras off.

Mechanism / How It Works

1. Recruitment: Grb2's SH2 domain binds a phosphotyrosine on the activated RTK; its SH3 domains bind proline-rich motifs on SOS, tethering SOS to the membrane near Ras.
2. Ras activation: SOS promotes release of GDP and binding of GTP (GTP is ~10-fold more abundant in the cell), generating Ras-GTP.
3. Raf recruitment and activation: Ras-GTP binds Raf, recruiting it to the membrane and relieving autoinhibition; Raf becomes an active kinase (with additional phosphorylation/dimerization steps).
4. Kinase cascade: Raf phosphorylates and activates MEK on two serines; MEK (a dual-specificity kinase) phosphorylates ERK on a Thr-Glu-Tyr motif. Each step amplifies the signal.
5. ERK outputs: Active ERK phosphorylates cytoplasmic targets (phospholipase A2, RSK) and translocates to the nucleus, where it phosphorylates transcription factors such as Elk-1, which combine with SRF to turn on immediate-early genes (c-Fos, c-Jun) that promote proliferation and differentiation.
6. Termination: GAPs (e.g., NF1) hydrolyze Ras-GTP → Ras-GDP; MAP kinase phosphatases (MKPs) dephosphorylate ERK.

Energy and Directionality

The pathway consumes ATP at each kinase step (Raf, MEK, ERK, RSK) and GTP at the Ras switch. Directionality and switch-like behavior come from several features: (1) the kinase cascade is a sequence of activating phosphorylations, each potentially amplifying; (2) Ras is a binary GTP/GDP switch; and (3) MEK's dual phosphorylation of ERK creates a sharp, ultrasensitive threshold — ERK activation is sigmoidal with respect to input. Turn-off is also active: GAP-stimulated GTP hydrolysis and phosphatase-mediated dephosphorylation reset the system. Sustained versus transient ERK activity is interpreted differently by the cell (proliferation vs. differentiation).

Experimental Evidence / Technique

• Oncogenic Ras: Missense mutations (G12V, G13, Q61L) block GTP hydrolysis and lock Ras ON; they are found in ~30% of human cancers — the first human oncogenes identified (Harvey and Kirsten sarcoma viruses).
• Dominant-negative Ras (e.g., S17N, which sequesters GEFs) blocks mitogen-induced proliferation, proving Ras is required.
• Constitutively active Raf or MEK (oncogenic v-Raf, or MEK with activating mutations) transforms cells and induces ERK activation without upstream signal.
• Phospho-specific antibodies (anti-pERK) and FRET-based Ras/ERK biosensors measure pathway activity in live cells.
• Ras farnesylation inhibitors and MEK inhibitors (trametinib) validate the pathway as a drug target.

How it works

1. Recruitment: Grb2's SH2 domain binds a phosphotyrosine on the activated RTK; its SH3 domains bind proline-rich motifs on SOS, tethering SOS to the membrane near Ras.
2. Ras activation: SOS promotes release of GDP and binding of GTP (GTP is ~10-fold more abundant in the cell), generating Ras-GTP.
3. Raf recruitment and activation: Ras-GTP binds Raf, recruiting it to the membrane and relieving autoinhibition; Raf becomes an active kinase (with additional phosphorylation/dimerization steps).
4. Kinase cascade: Raf phosphorylates and activates MEK on two serines; MEK (a dual-specificity kinase) phosphorylates ERK on a Thr-Glu-Tyr motif. Each step amplifies the signal.
5. ERK outputs: Active ERK phosphorylates cytoplasmic targets (phospholipase A2, RSK) and translocates to the nucleus, where it phosphorylates transcription factors such as Elk-1, which combine with SRF to turn on immediate-early genes (c-Fos, c-Jun) that promote proliferation and differentiation.
6. Termination: GAPs (e.g., NF1) hydrolyze Ras-GTP → Ras-GDP; MAP kinase phosphatases (MKPs) dephosphorylate ERK.

Common confusions

• Ras vs. heterotrimeric G proteins: Ras is a small, monomeric GTPase with no βγ subunits; heterotrimeric G proteins (Gs, Gq) are larger αβγ complexes coupled to GPCRs.
• GEF vs. GAP: GEFs turn small GTPases ON (promote GDP→GTP); GAPs turn them OFF (promote GTP hydrolysis). SOS = GEF; NF1 = GAP.
• Ras vs. Raf: Ras is the GTPase switch; Raf is the downstream kinase (MAPKKK). Oncogenic Ras activates Raf, but BRAF itself is frequently mutated in cancer.
• MEK's dual specificity: It phosphorylates both a threonine and a tyrosine on ERK, unlike purely Ser/Thr or purely Tyr kinases.

Quick review

• RTK-pTyr → Grb2(SH2) → Grb2(SH3) → SOS (GEF) → Ras-GDP → Ras-GTP.
• Ras-GTP → Raf (MAPKKK) → MEK (MAPKK) → ERK (MAPK) → Elk-1/SRF → immediate-early genes.
• Off: GAPs (NF1) and MAP kinase phosphatases.